Podcast
Agentic AI in Clinical Trials: How Maxis AI's Agents are Driving Evolution
Explore how purpose-built, context-powered AI agents are helping clinical teams move beyond traditional automation and scale intelligent execution across clinical research.
About this episode
What is Maxis AI—and why is it redefining the future of clinical trials?
In this episode, we explore the rise of Agentic AI and how Maxis AI is pioneering its application in clinical research. Join Nicole Powell, Senior Vice President at Maxis AI, and Moulik Shah, CEO & Founder of Maxis AI, as they answer the most frequently asked questions from clinical operations, data management, and R&D teams.
Discover how AI agents—built for purpose and powered by context—are enabling trial teams to go beyond traditional automation, with intelligent systems that adapt, prioritize, and act across a robust clinical data ecosystem.
Whether you are evaluating where to start or looking to scale AI across studies and therapeutic areas, this episode offers actionable insights grounded in real-world experience.
Key takeaways
- What Agentic AI is and how it differs from traditional automation and generative AI.
- What sets Maxis AI's AI agents apart—thanks to its end-to-end platform, industry experience, and early AI adoption.
- Debunking common myths around AI bias, human oversight, explainability, and scalability.
- The top challenges in scaling AI agents across therapeutic areas—and how a strong data foundation makes it possible.
- Where clinical teams should start the AI journey and what realistic adoption timelines look like.
Meet the Guests
Nicole Powell
Senior Vice President, Business Development, Maxis AI
Nicole is a strategic leader with over 17 years of experience in the clinical research industry. Her expertise lies in building strong partnerships and steering corporate strategies that align with evolving industry needs. At Maxis AI, she helps expand the reach of AI-powered clinical data analytics solutions so clients can streamline trials and achieve their objectives. She holds a BA from the University of Texas at San Antonio and an MBA from Baylor University.
Moulik Shah
Founder & CEO, Maxis AI
Moulik Shah is the Founder and CEO of Maxis AI, an enterprise agentic AI platform for the pharmaceutical and life sciences industry. With over 20 years of experience in healthcare technology, he has spent the majority of his career helping pharma, biotech, and CRO organizations modernize clinical trials through data and AI. He is a Forbes Technology Council contributor, writing on artificial intelligence and enterprise innovation.
Explore our AI Workforce Platform
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.